Showing 1 - 3 results of 3 for search 'Katerina Bakunina', query time: 0.02s Refine Results
  1. 1
    Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer

    Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer by Sarah Baker, Katerina Bakunina, Marloes Duijm, Mischa S. Hoogeman, Robin Cornelissen, Imogeen Antonisse, John Praag, Wilma D. Heemsbergen, Joost Jan Nuyttens

    Published 2020-04-01
    Get full text
    Article
  2. 2
    HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma

    HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Foll... by Wendy B.C. Stevens, Katerina Bakunina, Marloes Cuijpers, Martine Chamuleau, Aart Beeker, Rob Fijnheer, Holger Hebart, Hein P.J. Visser, Jeanette K. Doorduijn, Kim Linton, Martin Dreyling, Daphne de Jong, Marie José Kersten

    Published 2020-02-01
    Get full text
    Article
  3. 3
    The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed

    The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed by Katerina Bakunina, Hein Putter, Jurjen Versluis, Eva A. S. Koster, Bronno van derHolt, Markus G. Manz, Dimitri A. Breems, Bjorn T. Gjertsen, Jacqueline Cloos, Peter J. M. Valk, Jakob Passweg, Thomas Pabst, Gert J. Ossenkoppele, Bob Löwenberg, Jan J. Cornelissen, Liesbeth C. deWreede

    Published 2022-02-01
    Get full text
    Article

Search Tools: